CheckMyRecalls

McKesson recalls Gemcitabine Injection

Published
8 Jul 2026
Units affected
74 units
Agency
FDA
Country
United States

The hazard

Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01

Brand / company
McKesson
Codes / lots
Lot #: CB0046, Exp. Date 06/2027
Distribution
Nationwide within the United States
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 8 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.